Assessing therapeutic turnaround time of creatinine, urea and FBC from emergency departments at Queens central hospital
| dc.contributor.author | Gondwe, Yilinase | |
| dc.date.accessioned | 2021-12-20T16:30:44Z | |
| dc.date.available | 2021-12-20T16:30:44Z | |
| dc.date.issued | 2021-01-16 | |
| dc.description | An observational descriptive study will be conducted on creatinine, urea and full blood count testing requests from the adult emergency department delivered at the Clinical Chemistry and hematology section of the Queens Elizabeth Central hospital (QECH) laboratory department | en_US |
| dc.description.abstract | Type of research An observational descriptive study will be conducted on creatinine, urea and full blood count testing requests from the adult emergency department delivered at the Clinical Chemistry and hematology section of the Queens Elizabeth Central hospital (QECH) laboratory department The problem to be studied Therapeutic turnaround time is the period from test ordering to the time the results for the test are given. Clinicians rely on shortness of turnaround time (TAT) to achieve early diagnosis, treatment of the patients and early patient discharge from emergency departments or hospital in-patient services and the hospital as a whole. A clear knowledge of Laboratory Turnaround Time (LTAT) will enable critical assessment of laboratory services and improve therapeutic turnaround time (TTAT), thus improve care provision and shorten the length of stay in the emergency department. Objectives This study will define the therapeutic turnaround time for creatinine, blood urea nitrogen (BUN) and full blood count (FBC) tests from the adult emergency department at Queen Elizabeth Central Hospital (QECH). Specifically, this study will quantify the demand for creatinine, urea and full blood count tests from the adult emergency department; and further identify factors affecting the turnaround time for these tests in the emergency department and at in a clinical laboratory. Methodology Blood samples will be received at the Clinical Chemistry Department for creatinine and urea and at hematology department for full blood count within the QECH laboratory department. A number of tests will be observed in a time period of a month and a sample size of 196 will be observed. Average time taken to complete each phase of the test will be measured and overall turnaround time for each test will be calculated. Clinical data. Emergency department and laboratory issues identified as affecting the turnaround time will be categorized and reported in proportions to define the demand and describe the factors affecting the TTAT. EPI Info 7.0 will be used for data analysis. 163.5 Expected findings and dissemination The expectation is that the TTAT identified in this study will be more than 60 minutes which is the acceptable TTAT as described by Robert Hawkins. The study findings will be presented to the Medical laboratory science (MLS) department, QECH emergency and laboratory departments. The final study report will be submitted to College of Medicine Research and Ethics Committee (COMREC) and college of medicine library. These results will be disseminated through attendance of local conferences/seminars and publication in peer-reviewed journal. | en_US |
| dc.description.sponsorship | Kamuzi University of Health Sciences | en_US |
| dc.identifier.uri | http://rscarchive.kuhes.ac.mw/handle/20.500.12988/597 | |
| dc.language.iso | en | en_US |
| dc.publisher | Kamuzu University of Health Science | en_US |
| dc.relation.ispartofseries | U.05/21/3325; | |
| dc.title | Assessing therapeutic turnaround time of creatinine, urea and FBC from emergency departments at Queens central hospital | en_US |
| dc.type | Other | en_US |